06.04.2013 Views

toxicological profile for malathion - Agency for Toxic Substances and ...

toxicological profile for malathion - Agency for Toxic Substances and ...

toxicological profile for malathion - Agency for Toxic Substances and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

MALATHION 135<br />

3. HEALTH EFFECTS<br />

Kearns 1997; NRC 1993; Vieira et al. 1996). Whether differences in xenobiotic metabolism make the<br />

child more or less susceptible also depends on whether the relevant enzymes are involved in activation of<br />

the parent compound to its toxic <strong>for</strong>m or in detoxification. There may also be differences in excretion,<br />

particularly in newborns who all have a low glomerular filtration rate <strong>and</strong> have not developed efficient<br />

tubular secretion <strong>and</strong> resorption capacities (Altman <strong>and</strong> Dittmer 1974; NRC 1993; West et al. 1948).<br />

Children <strong>and</strong> adults may differ in their capacity to repair damage from chemical insults. Children also<br />

have a longer remaining lifetime in which to express damage from chemicals; this potential is particularly<br />

relevant to cancer.<br />

Certain characteristics of the developing human may increase exposure or susceptibility, whereas others<br />

may decrease susceptibility to the same chemical. For example, although infants breathe more air per<br />

kilogram of body weight than adults breathe, this difference might be somewhat counterbalanced by their<br />

alveoli being less developed, which results in a disproportionately smaller surface area <strong>for</strong> alveolar<br />

absorption (NRC 1993).<br />

No studies were located that specifically addressed effects of exposure to <strong>malathion</strong> in children. Children<br />

could be exposed to <strong>malathion</strong> from food <strong>and</strong> drinking water, but these risks are low <strong>and</strong> not of concern.<br />

Greater concern exists from postapplication residential exposure to turf treatments, from other home <strong>and</strong><br />

garden uses of <strong>malathion</strong>, <strong>and</strong> as byst<strong>and</strong>ers from special uses of <strong>malathion</strong> in public health mosquito<br />

abatement control <strong>and</strong> the USDA’s (U.S. Department of Agriculture) Boll Weevil Eradication Program.<br />

Because children spend more time outdoors than adults, they may be at a greater risk of exposure to<br />

<strong>malathion</strong> than nonoccupationally exposed adults by dermal contact with contaminated surfaces or by<br />

h<strong>and</strong>-mouth activity. Malathion is an organophosphate pesticide, <strong>and</strong> acute exposure to high amounts<br />

results in typical <strong>and</strong> easily recognizable signs of poisoning (Aaron <strong>and</strong> Howl<strong>and</strong> 1998; Abou-Donia<br />

1995; Ecobichon 1994; Taylor 1996). As detailed in Section 3.5.2, Mechanisms of <strong>Toxic</strong>ity, the primary<br />

target of <strong>malathion</strong> toxicity is the nervous system <strong>and</strong> secondary ocular, exocrine gl<strong>and</strong>s, gastrointestinal,<br />

cardiovascular, <strong>and</strong> respiratory effects can be observed as a result of the excess acetylcholine at nerve<br />

terminals innervating tissues <strong>and</strong> organs from these systems. The most common manifestations of<br />

poisoning with organophosphates in general are increased salivation <strong>and</strong> lacrimation, miosis <strong>and</strong> blurred<br />

vision, nausea, vomiting, abdominal cramps <strong>and</strong> diarrhea, excessive bronchial secretions <strong>and</strong> dyspnea,<br />

bradycardia <strong>and</strong> low blood pressure, muscle fasciculations, muscle weakness in peripheral <strong>and</strong> respiratory<br />

muscles, <strong>and</strong> fatigue <strong>and</strong> mental confusion. Several reports have described these manifestations in<br />

children following oral poisoning with <strong>malathion</strong> (Ekin 1971; Healy 1959; Jušić <strong>and</strong> Milić 1978; Tuthill<br />

1958) <strong>and</strong> dermal exposure (Parker <strong>and</strong> Chattin 1955; Ramu et al. 1973), <strong>and</strong> it does not appear that there

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!